Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

aCGH-MAS: analysis of aCGH by means of multiagent system.

De Paz JF, Benito R, Bajo J, Rodríguez AE, Abáigar M.

Biomed Res Int. 2015;2015:194624. doi: 10.1155/2015/194624. Epub 2015 Mar 22.

2.

Interplay of radiative and nonradiative transitions in surface hopping with radiation-molecule interactions.

Bajo JJ, Granucci G, Persico M.

J Chem Phys. 2014 Jan 28;140(4):044113. doi: 10.1063/1.4862738.

PMID:
25669511
3.

Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.

Apter D, Wheeler CM, Paavonen J, Castellsagué X, Garland SM, Skinner SR, Naud P, Salmerón J, Chow SN, Kitchener HC, Teixeira JC, Jaisamrarn U, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Mindel A, de Sutter P, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Clin Vaccine Immunol. 2015 Apr;22(4):361-73. doi: 10.1128/CVI.00591-14. Epub 2015 Feb 4.

4.

Ambient agents: embedded agents for remote control and monitoring using the PANGEA platform.

Villarrubia G, De Paz JF, Bajo J, Corchado JM.

Sensors (Basel). 2014 Jul 31;14(8):13955-79. doi: 10.3390/s140813955.

5.

Monitoring and detection platform to prevent anomalous situations in home care.

Villarrubia G, Bajo J, De Paz JF, Corchado JM.

Sensors (Basel). 2014 Jun 5;14(6):9900-21. doi: 10.3390/s140609900.

6.

Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.

Roset Bahmanyar E, Paavonen J, Naud P, Salmerón J, Chow SN, Apter D, Kitchener H, Castellsagué X, Teixeira JC, Skinner SR, Jaisamrarn U, Limson GA, Garland SM, Szarewski A, Romanowski B, Aoki F, Schwarz TF, Poppe WA, De Carvalho NS, Harper DM, Bosch FX, Raillard A, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Gynecol Oncol. 2012 Dec;127(3):440-50. doi: 10.1016/j.ygyno.2012.08.033. Epub 2012 Aug 30.

7.

Automatic knowledge extraction in sequencing analysis with multiagent system and grid computing.

González R, Zato C, Benito R, Bajo J, Hernández JM, De Paz JF, Vera V, Corchado JM.

J Integr Bioinform. 2012 Jul 24;9(3):206. doi: 10.2390/biecoll-jib-2012-206.

PMID:
22829577
8.

Mixed quantum-classical dynamics in the adiabatic representation to simulate molecules driven by strong laser pulses.

Bajo JJ, González-Vázquez J, Sola IR, Santamaria J, Richter M, Marquetand P, González L.

J Phys Chem A. 2012 Mar 22;116(11):2800-7. doi: 10.1021/jp208997r. Epub 2012 Jan 5.

PMID:
22168132
9.

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagué X, Skinner SR, Apter D, Naud P, Salmerón J, Chow SN, Kitchener H, Teixeira JC, Hedrick J, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, De Carvalho NS, Germar MJ, Peters K, Mindel A, De Sutter P, Bosch FX, David MP, Descamps D, Struyf F, Dubin G; HPV PATRICIA Study Group.

Lancet Oncol. 2012 Jan;13(1):89-99. doi: 10.1016/S1470-2045(11)70286-8. Epub 2011 Nov 8. Erratum in: Lancet Oncol. 2012 Jan;13(1):e1.

PMID:
22075171
10.

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

Wheeler CM, Castellsagué X, Garland SM, Szarewski A, Paavonen J, Naud P, Salmerón J, Chow SN, Apter D, Kitchener H, Teixeira JC, Skinner SR, Jaisamrarn U, Limson G, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Harper DM, Huh W, Hardt K, Zahaf T, Descamps D, Struyf F, Dubin G, Lehtinen M; HPV PATRICIA Study Group.

Lancet Oncol. 2012 Jan;13(1):100-10. doi: 10.1016/S1470-2045(11)70287-X. Epub 2011 Nov 8. Erratum in: Lancet Oncol. 2012 Jan;13(1):e1.

PMID:
22075170
11.

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18.

Szarewski A, Poppe WA, Skinner SR, Wheeler CM, Paavonen J, Naud P, Salmeron J, Chow SN, Apter D, Kitchener H, Castellsagué X, Teixeira JC, Hedrick J, Jaisamrarn U, Limson G, Garland S, Romanowski B, Aoki FY, Schwarz TF, Bosch FX, Harper DM, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Int J Cancer. 2012 Jul 1;131(1):106-16. doi: 10.1002/ijc.26362. Epub 2011 Oct 23.

PMID:
21858807
12.

Hybrid neural intelligent system to predict business failure in small-to-medium-size enterprises.

Borrajo ML, Baruque B, Corchado E, Bajo J, Corchado JM.

Int J Neural Syst. 2011 Aug;21(4):277-96.

PMID:
21809475
13.

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.

Leiter LA, Lundman P, da Silva PM, Drexel H, Jünger C, Gitt AK; DYSIS investigators.

Diabet Med. 2011 Nov;28(11):1343-51. doi: 10.1111/j.1464-5491.2011.03360.x.

PMID:
21679231
14.

Relationship between the lung function and anthropometric measures and indexes in adolescents from Córdoba, Argentina.

Bajo JM, Mangeaud A.

Am J Hum Biol. 2010 Nov-Dec;22(6):823-9. doi: 10.1002/ajhb.21090.

PMID:
20857411
15.

Applying wearable solutions in dependent environments.

Fraile JA, Bajo J, Corchado JM, Abraham A.

IEEE Trans Inf Technol Biomed. 2010 Nov;14(6):1459-67. doi: 10.1109/TITB.2010.2053849. Epub 2010 Jul 26.

PMID:
20667814
16.

Using heterogeneous wireless sensor networks in a telemonitoring system for healthcare.

Corchado JM, Bajo J, Tapia DI, Abraham A.

IEEE Trans Inf Technol Biomed. 2010 Mar;14(2):234-40. doi: 10.1109/TITB.2009.2034369. Epub 2009 Oct 23.

PMID:
19858034
17.

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Lancet. 2009 Jul 25;374(9686):301-14. doi: 10.1016/S0140-6736(09)61248-4. Epub 2009 Jul 6. Erratum in: Lancet. 2010 Sep 25;376(9746):1054.

PMID:
19586656
18.

Model of experts for decision support in the diagnosis of leukemia patients.

Corchado JM, De Paz JF, Rodríguez S, Bajo J.

Artif Intell Med. 2009 Jul;46(3):179-200. doi: 10.1016/j.artmed.2008.12.001. Epub 2009 Jan 8.

PMID:
19135343
19.

Raloxifene plus ossein-hydroxyapatite compound versus raloxifene plus calcium carbonate to control bone loss in postmenopausal women: a randomized trial.

Pelayo I, Haya J, De la Cruz JJ, Seco C, Bugella JI, Diaz JL, Bajo JM, Repolles M.

Menopause. 2008 Nov-Dec;15(6):1132-8. doi: 10.1097/gme.0b013e318170af33.

PMID:
18791486
20.

Clinical usefulness of 3-dimensional sonography and power Doppler angiography for diagnosis of endometrial carcinoma.

Mercé LT, Alcázar JL, López C, Iglesias E, Bau S, Alvarez de los Heros J, Bajo JM.

J Ultrasound Med. 2007 Oct;26(10):1279-87.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk